KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $10.4 million.

  • Guardant Health's Capital Expenditures rose 14648.73% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year increase of 9388.28%. This contributed to the annual value of $35.1 million for FY2024, which is 7126.33% up from last year.
  • Guardant Health's Capital Expenditures amounted to $10.4 million in Q3 2025, which was up 14648.73% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Capital Expenditures ranged from a high of $24.6 million in Q4 2021 and a low of $2.4 million during Q3 2023
  • Its 5-year average for Capital Expenditures is $12.0 million, with a median of $9.6 million in 2021.
  • As far as peak fluctuations go, Guardant Health's Capital Expenditures plummeted by 8908.22% in 2023, and later soared by 36296.3% in 2024.
  • Over the past 5 years, Guardant Health's Capital Expenditures (Quarter) stood at $24.6 million in 2021, then tumbled by 59.39% to $10.0 million in 2022, then plummeted by 59.23% to $4.1 million in 2023, then skyrocketed by 362.96% to $18.9 million in 2024, then crashed by 45.17% to $10.4 million in 2025.
  • Its Capital Expenditures stands at $10.4 million for Q3 2025, versus $5.6 million for Q2 2025 and $4.5 million for Q1 2025.